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Abstract
Objectives Acute diplopia is a diagnostic challenge for clinicians, in particular in the emergency department. The most 
common cause of acute diplopia are ocular motor nerve palsies (OMP). In this prospective study, we focused on identifying 
the most crucial signs and symptoms for differentiating between peripheral and central OMP.
Methods We prospectively evaluated 56 non-consecutive patients who presented at our emergency department with acute 
binocular diplopia (≤ 10 days). The patient history was taken using a standardized questionnaire and patients underwent a 
neurological, neuro-ophthalmological and neuro-otological examination, including measurement of the subjective visual 
vertical (SVV), Harms tangent screen test, and cranial MRI.
Results Forty-six out of 56 patients were diagnosed with an ocular motor cranial nerve palsy (OMP), 21 of peripheral and 
23 of central origin; in two patients, the etiology remained unknown. The following features were different in peripheral and 
central OMP: (1) the presence of vertigo/dizziness was more frequent in central (43.5%) than in peripheral (9.5%) OMP. (2) 
Central ocular motor signs, such as saccadic smooth pursuit, additional internuclear ophthalmoplegia, skew deviation, and 
saccade palsies, were also found more frequently in the central than in the peripheral group (86.7% vs. 33.3%). (3) Further, 
a pathological SVV deviation by monocular testing of the non-affected eye was also more common in central (77.3%) than 
in peripheral OMP (38.9%). The presence of all three factors has a positive predictive value of 100% (CI 50–100%) for the 
presence of a central lesion.
Conclusions In acute diplopia due to central OMP, the most important accompanying symptom is vertigo/dizziness, and the 
most important clinical signs are central ocular motor disorders (which require examination of the non-paretic eye) and an 
SVV deviation in the non-paretic eye.
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Introduction
Acute diplopia (perception of two different images) 
accounts for 0.1% of the patients that present at an emer-
gency department [1]. An ocular misalignment of more 
than 200 µm [2] can cause binocular diplopia [3].
The most common causes of acute binocular diplopia 
are acute third (CNIII), fourth (CNIV) and sixth (CVI) 
cranial nerve palsies [1, 4, 5] (ocular motor palsies: OMP). 
The ocular motor nuclei are located throughout the brain-
stem, from the midbrain (CNIII) to the pons (CNIV) and 
the ponto-medullary junction (CNVI). Within the brain-
stem they have a long (CNIII, CNVI) or short (CNIV) 
so-called fascicular part [6]. After exiting the brainstem 
heading towards the eye, they pass through critical struc-
tures, such as the cavernous sinus. Because of their com-
plicated anatomy and vicinity to these structures, prompt 
diagnosis of the localization of the OMP lesion is both 
very difficult and very important, in particular to diagnose 
a brainstem stroke. The importance of a prompt diagnosis 
in the emergency department is shown in a large prospec-
tive study [7], where 16% of the 50,000 emergency depart-
ment visits due to diplopia were due to a life-threatening 
underlying disease.
There have been several prospective and retrospective 
studies on the etiologies of acute OMPs, each from a dif-
ferent point of view [5, 8–13]. The underlying diseases 
range from microvascular to acute life-threatening dis-
eases, although the reported frequencies vary greatly from 
study to study.
In addition, Dieterich and Brandt have previously 
shown the important role of measuring mono- and bin-
ocular subjective visual verticality in the differentiation 
between a central and a peripheral lesion [14, 15].
In this study, we focus on the clinical differentiation of 
peripheral versus central OMPs in the acute phase in an 
effort to identify signs and symptoms that would assist 
a non-specialist in the emergency department in making 
the correct clinical decision regarding further diagnostic 
procedures and management.
Methods
Over a period of 3 years, we prospectively recruited adult 
(≥ 18 years) patients from the neurological emergency 
department of Campus Grosshadern of the Ludwig Maxi-
milian University, Munich, who presented because of 
acute diplopia. Diplopia had to be present for less than 
10 days and be the leading symptom and the main cause 
for the patient’s referral to our department. Patients with 
monocular diplopia or binocular diplopia due to known 
pre-existing causes, such as myasthenia, were excluded 
from the study.
At the time of presentation, all patients underwent a 
complete clinical–neurological evaluation and had to 
answer a study questionnaire regarding their symptoms 
and presentation of diplopia. Furthermore, blood samples 
were obtained. A standardized neuro-ophthalmological 
and neuro-orthoptic examination, including Harms tangent 
screen [16] and monocular (each eye separately) measure-
ments of the subjective visual vertical (SVV) [14, 15, 17], 
was performed on the same or the following day. The SVV 
was measured using either the bucket test or a dome. The 
SVV test was performed by an experienced orthoptician, 
who rotated the bucket manually and slowly from a rand-
omized offset position towards zero, alternating between 
the two directions in each trial. The patient looked with 
one eye (the other eye was covered with an eye patch) at 
a straight line visible on the inner bottom of a bucket or 
of a dome without other visual cues, and had to align it 
properly, indicating the vertical position verbally. On the 
outer bottom surface of the bucket, an angular protractor 
allowed the examiner to readout the tilt angle; when the 
dome was used, the tilt angle was computed automatically 
[17]. Central ocular motor signs included saccadic smooth 
pursuit, saccade palsy, internuclear ophthalmoplegia, and 
skew deviation (in addition to the ocular motor palsy).
All patients but one (in whom the underlying diagnosis 
was evident in computed tomography) received an MRI 
(with DWI and MR angiography) 1–10 days after presen-
tation. Lumbar puncture was performed when clinically 
indicated and when the cause of the OMP could not be 
detected in the MRI, meaning that it was performed in 
all patients with peripheral lesions, except for a patient 
with posttraumatic trochlear palsy. The final diagnosis 
was made taking into account all clinical, radiological and 
laboratory findings.
The patients were then divided into two categories 
according to their final diagnosis: peripheral or central 
OMP. Central OMP included both nuclear and fascicular 
lesions. The criteria for microvascular, peripheral OMP 
were based on the following criteria, reported earlier [18]: 
(1) isolated OMP (CNIII pupil sparing), (2) ESR less than 
30 mm/hr and normal CRP, (3) age of 50 years or older, 
and (4) at least one of the cardiovascular risk factors: dia-
betes, hypertension, hyperlipidemia or smoking.
Fisher’s exact test, Chi-square test and Kruskal–Wallis 
test were used to compare the two groups. Statistical sig-
nificance was set at p < 0.05. Statistical analysis was per-
formed using IBM SPSS Statistics (Version 25.0.1), and 
calculation of sensitivity, specificity, positive and nega-
tive predictive value, and likelihood ratios was performed 
using vassarstats.net.
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Results
Fifty-six patients were initially recruited for the study. Ten of 
them were subsequently excluded after neuro-ophthalmolog-
ical examination revealed another cause for the diplopia than 
an OMP (two patients with solely internuclear ophthalmo-
plegia, five patients with solely skew deviation, one patient 
with decompensated strabismus, one patient with thyroid 
disease and one patient with isolated inferior rectus muscle 
palsy due to IgG4-associated disease).
In the remaining 46 patients, a cause of the palsy could 
be identified in 44 patients. The two remaining patients had 
negative MRI and CSF findings and did not fulfill the cri-
teria for any other disease (such as age and presence of car-
diovascular risk factors), and were thus not included in the 
statistical evaluation.
The etiologies of the OMP are summarized in Table 1. 
Two patients with peripheral OMP (the patient with Fisher 
syndrome and the patient with idiopathic intracranial hyper-
tension) and one with central OMP (glioma) had bilateral 
CNVI palsies.
The results of the statistical comparison between the two 
groups are given in Table 2. The two groups did not differ 
statistically regarding age or gender. In both groups, CNVI 
was the most commonly affected, followed by CNIII and 
CNIV. Pupil involvement was documented in two out of 
nine patients with peripheral CNIII lesions (one with neu-
roborreliosis and one with sarcoidosis) and in two out of five 
patients with central lesions (both strokes).
Both patient groups had their first medical contact on 
average 2 days after diplopia onset and were seen in our 
department on the same day or a day later. 70% of the 
patients had acute onset diplopia, in 23% the diplopia was 
progressive, and 7% of patients woke up with the symptoms 
(no difference between groups).
Regarding patients’ symptoms, statistical analysis showed 
that more central OMP patients reported concomitant ver-
tigo or dizziness, whereas headache and/or periorbital pain 
were reported equally in both groups. Furthermore, both 
groups did not differ in terms of the presence of other neu-
rological symptoms (such as hypoesthesia and paresthesia).
Regarding the clinical and neuro-ophthalmological find-
ings, 87% of patients with a central OMP had additional 
central ocular motor deficits (such as spontaneous nystag-
mus, saccadic smooth pursuit, saccadic palsy on the healthy 
eye, internuclear ophthalmoplegia or skew deviation that 
was not justified by the underlying palsy, e.g. in CNVI pal-
sies). 77% of the non-paretic eyes of patients with central 
OMP showed a pathological > 2.5° deviation, which was sig-
nificantly more than in peripheral OMP (Table 2). One non-
paretic eye in one patient with peripheral OMP could not 
be tested, due to severe congenital amblyopia. The patient 
groups showed no difference regarding the presence of other 
neurological signs.
Based on these findings, we calculated the sensitivity, 
specificity, positive predictive value, and negative predictive 
value of these three signs and symptoms (vertigo/dizziness, 
pathological subjective visual vertical in the non-paretic 
eye—SVVnp—and central ocular motor disorders-Omd) 
for identifying a central lesion (Table 3).
According to our data, the concomitant presence of all 
three factors has a 100% specificity (CI 81–100%) and 100% 
positive predictive value (CI 50–100%). Therefore, a patient 
with OMP that reports vertigo or dizziness and has patho-
logical SVV and central ocular motor disorder (Omd) on the 
non-affected eye most likely has a brainstem lesion.
Discussion
The major finding of this study is that a differentiation 
between a central and a peripheral OMP lesion can be made 
clinically on the basis of the combination of (a) the patient 
history (presence of vertigo/dizziness or not), (b) neuro-
ophthalmological examination of the non-paretic eye (cen-
tral ocular motor disorders or not), and (c) measurement of 
subjective visual verticality on the non-affected eye [14].
In both our groups, CNVI was the most common doc-
umented palsy, followed by CNIII and CNIV, which is in 
line with previous literature [5, 8–13]. Clinically, a central 
lesion can be assumed with certainty only if the nuclei are 
involved: CNIII nuclear lesions can cause ipsilateral oph-
thalmoplegia with upgaze palsy and bilateral ptosis, CNIV 
nuclear lesions are associated with an ipsilateral Horner’s 
syndrome, and CNVI nuclear lesions with ipsilateral hori-
zontal gaze palsy [19]. Nevertheless, these nerves, espe-
cially CNIII and CNVI, have a significant fascicular course 
through the brainstem [6] that cannot in itself be clinically 
Table 1  Etiologies of peripheral and central OMP
ACI internal carotid artery, IIH idiopathic intracranial hypertension, 
OM ophthalmoplegic migraine, MS multiple sclerosis
Peripheral Central
Etiology # Etiology #
Ischemic 9 Ischemic 11
Infection 3 MS 7
Tumor 2 Tumor 3
Neurosarcoidosis 2 Vasculitis 1
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differentiated with the same certainty from purely peripheral 
lesions.
Separating a brainstem stroke from a microvascular lesion 
is important for further therapeutic decisions; although 
secondary prophylaxis is mandatory in stroke, there is no 
evidence for or against the use of aspirin or oral anticoagu-
lation in microvascular lesions. For example, in a retrospec-
tive study, aspirin did not have a protective effect against 
microvascular OMPs [20].
Although the presence of central ocular motor signs 
seems at first self-evident in central lesions, examination of 
the non-paretic eye is in our experience often neglected in 
clinical routine. Although most studies and reviews study-
ing acute diplopia due to OMP concentrate on the clinical 
features of the paretic eye, our study further emphasizes the 
importance of a systematic examination of the central ocu-
lar motor system (saccades, smooth pursuit, cover test to 
unmask a skew deviation) in the non-paretic eye to detect a 
Table 2  Clinical characteristics 
of the peripheral and central 
OMP groups 
Bold indicates statistical significance
p refers to Fisher’s exact test for 2 × 2 tables and Chi square for 3 × 2 tables, apart from # that refers to the 
Kruskal–Wallis test
Peripheral Central Total p value
# Patients 21 (47.7%) 23 (52.3%) 44
Ocular motor cranial nerve palsies 23 (48.9%) 24 (51.1%) 47
 CNIII 9 (39.1%) 5 (20.8%) 14 (29.8%) 0.26
 CNIV 4 (17.4%) 3 (12.5%) 7 (14.9%)
 CNVI 10 (43.5%) 16 (66.7%) 26 (55.3%)
Age ± SD (years) 58.8 ± 14.6 58.9 ± 17.2 58.8 ± 16.5 0.86#
Gender (women) 4 (19.0%) 11 (47.8%) 15 (34.1%) 0.06
First medical contact ± SD (days) 1.8 ± 0.9 2.1 ± 2.2 2.0 ± 2.2 0.46#
Neurological emergency ± SD (days) 2.9 ± 1.7 2.3 ± 2.2 2.5 ± 2.7 0.93#
Manifestation
 Acute 15 (71.4%) 16 (69.6%) 31 (70.5%) 1
 Progressive 5 (23.8%) 5 (21.7%) 10 (22.7%)
 Woke up 1 (4.8%) 2 (8.7%) 3 (6.8%)
Duration of symptoms
 Permanent 18 (85.7%) 19 (82.6%) 37 (84.1%) 0.20
 Increasing 2 (9.5%) 0 (0%) 2 (4.5%)
 Fluctuating 1 (4.8%) 4 (17.4%) 5 (11.4%)
Cardiovascular risk factors 1.6 ± 1.3 1.7 ± 1.4 1.6 ± 1.3 0.80#
Headache/periorbital pain 9 (42.9%) 6 (26.1%) 15 (34.1%) 0.34
Vertigo/dizziness 2 (9.5%) 10 (43.5%) 12 (27.3%) 0.0174
Other neurological symptoms 3 (14.3%) 4 (17.4%) 7 (15.9%) 1
Pathological SVV deviation paretic eye 10 (43.5%) 13 (54.2%) 23 (48.9%) 0.58
Pathological SVV deviation non-paretic eye 7 (38.9%) 17 (77.3%) 24 (60.0%) 0.023
Central ocular motor signs 7 (33.3%) 20 (86.7%) 27 (61.4%) 0.0005
Other neurological signs 7 (33.3%) 10 (43.5%) 17 (38.6%) 0.55
Table 3  Diagnostic performance of central ocular motor disorder (Omd), SVV deviation in the non-paretic eye (SVVnp) and vertigo/dizziness 
(V/D) for detecting central OMP
PPV positive predictive value, NPV negative predictive value, LR+ positive likelihood ratio, LR− negative likelihood ratio
Sensitivity Specificity PPV NPV LR+ LR−
Central OMP with Omd 0.87 (0.37–0.67) 0.67 (0.43–0.84) 0.74 (0.53–0.88) 0.82 (0.56–0.95) 2.61 (1.39–4.87) 0.19 (0.06–0.59)
Central OMP with SVVnp 0.77 (0.54–0.91) 0.61 (0.36–0.81) 0.71 (0.49–0.87) 0.69 (0.41–0.88) 1.98 (1.07–3.70) 0.37 (0.16–0.86)
Central OMP with V/D 0.43 (0.24–0.65) 0.90 (0.68–0.98) 0.83 (0.51–0.97) 0.59 (0.40–0.76) 4.57 (1.13–18.5) 0.62 (0.43–0.90)
Central OMP with all three 
factors
0.35 (0.17–0.57) 1 (0.81–1) 1 (0.50–1) 0.58 (0.41–0.74) Infinity 0.65 (0.48–0.88)
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brainstem lesion [21]. The centers for ocular motor and ves-
tibular control are abundant throughout the brainstem [22] 
and adjacent to the ocular motor nerve nuclei and fascicles. 
Therefore, a central brainstem lesion that affects them is also 
very likely to cause further central ocular motor deficits. 
Over the last years, clinical examination of the ocular motor 
system has been shown to be superior to MRI in identify-
ing brainstem lesions [23–25], especially because ischemic 
brainstem lesions are often only detectable in the DWI more 
than 72 h after symptom onset [26]. Central ocular motor 
signs on the non-paretic eye are nevertheless not sufficient 
in themselves, since in our peripheral group 33.3% of all 
patients had central ocular motor signs (mostly saccadic 
smooth pursuit), which could be pre-existent in many of 
them.
A significant SVV deviation during binocular testing is 
considered to be a sign of dysfunction in the graviceptive 
pathways [27]. The importance of monocular) SVV test-
ing for the differentiation of acute brainstem lesions from 
peripheral ocular motor palsies was already described 
before [14, 15]. In a retrospective study [14], about 40% of 
peripheral OMP showed a pathological SVV deviation in the 
affected eye during monocular testing, which was attributed 
to changes in visual perception through a lack of afferent 
extra-retinal information that codes the eye position in space. 
A pathological SVV in the non-paretic eye was previously 
documented only in chronic peripheral OMP [14] as a sign 
of central compensation for the contralateral palsy or in 
acute vascular brainstem lesions, representing an additional 
vestibular deficit in the roll plane [15].
The current work prospectively compares directly monoc-
ular SVV testing in acute peripheral versus central OMP. 
Monocular SVV deviation (> 2.5°) was observed in about 
50% of all paretic eyes, independent of the localization of 
the lesion and the type of palsy. Regarding the non-paretic 
eye, pathologic SVV deviation was found in 77% of central 
lesions. This could be attributed to concomitant lesions in 
the graviceptive vestibular pathways that are anatomically 
adjacent to the ocular motor nuclei and fascicles [28]. In 
accordance with this, vertigo/dizziness were also reported 
more often in central than in peripheral OMP in our study. 
The patients with peripheral palsies described the sensation 
as dizziness. In the central group, one patient described a 
rotational vertigo sensation and two a falling tendency to one 
side (one to the right and one to the left), the rest described 
a dizziness sensation as well.
Surprisingly, there was also a small percentage of 
patients with peripheral OMP that showed a pathological 
SVV deviation when tested monocularly while viewing 
with the non-affected eye. In these patients, the pathologi-
cal SVV deviation could be attributed either to an early 
compensation (like in the chronic OMP lesions [14]) or to 
an additional subclinical peripheral lesion in the seemingly 
healthy eye caused by a systemic disease, e.g. infection or 
sarcoidosis. Therefore, pathological SVV deviation in the 
clinically unaffected eye would justify further diagnostic 
steps (e.g. MRI, lumbar puncture), even if the OMP itself 
is clearly peripheral. The bedside examination of the SVV 
can be easily done using the bucket test [17].
Although pain is often postulated to be a feature of 
microvascular, peripheral OMP [29], patients with central 
lesions reported pain and ipsilateral headache as often as 
patients with peripheral palsy, especially when the central 
palsies were associated with a brainstem mass. There were 
no significant differences in the character of pain between 
the two groups; especially in the peripheral group, the pain 
was often described as diffuse and not strictly periorbital 
in our view. These findings undermine the significance of 
pain as the most significant diagnostic factor for a purely 
peripheral OMP.
The presence of other neurological signs did not exclude 
a peripheral lesion. Our patients with peripheral palsies also 
reported other neurological signs, such as hypesthesia, usu-
ally when the underlying disease affected other peripheral 
nerves, such as in the patient with Fisher syndrome.
Pupil sparing in CNIII palsy is usually considered a 
peripheral sign. In our study though, three out of five 
patients with central OMP did not have pupil involvement, 
which can be the case when the lesion is fascicular [3, 30]. 
On the other hand, two out of nine peripheral patients with 
CNIII palsy (due to sarcoidosis and neuroborreliosis) had 
pupil involvement.
The main findings are summed up in Fig. 1. Based on 
our data, we suggest the phrase (D)on’t (S)nub the (O)ther 
Eye (Dizziness, SVV and Ocular motor disorder of the 
non-paretic eye) as a mnemonic device for remembering 
these three factors that can assist the clinician in differen-
tiating between acute peripheral and central OMP.
Fig. 1  Number of positive cases of Dizziness/vertigo, SVV deviation 
and central Ocular motor disorder (Omd) in the non-paretic eye. The 
initials (DSO) can be remembered using the mnemonic device “Don’t 
Snub the Other eye”
 Journal of Neurology
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